The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

Inclusion Criteria: * To be a Turkish citizen, * To be \>18 years of age, * Lesion must be successfully crossed with a guidewire without complication, * INVADER™ PTCA is used in the primary lesion treated during the procedure, * Patient has signed and dated the informed consent. Exclusion Criteria: * Patients who have a known allergic reaction to any of the composition of INVADER™ PTCA Balloon Dilatation Catheter. * Device use not consistent with Instructions for Use (IFU). * Patients concurrently participating in another medical device or pharmaceutical clinical trial.